Loading...
XSHE
300358
Market cap686mUSD
Jul 09, Last price  
7.89CNY
1D
-1.25%
1Q
-21.41%
Jan 2017
-54.23%
IPO
-25.07%
Name

Truking Technology Ltd

Chart & Performance

D1W1MN
XSHE:300358 chart
P/E
18.29
P/S
0.81
EPS
0.43
Div Yield, %
1.27%
Shrs. gr., 5y
1.17%
Rev. gr., 5y
1.84%
Revenues
5.76b
-1.14%
139,239,006193,911,520355,269,864404,544,817588,699,882797,205,6821,005,189,784974,828,682975,042,9751,280,416,1331,631,790,5593,140,357,0393,576,213,3915,259,872,9525,259,872,9516,445,551,3056,445,551,3056,853,359,5425,829,800,5755,763,180,352
Net income
255m
P
15,455,85022,626,26253,175,01570,232,42595,367,795134,975,698156,906,216153,389,019120,063,838160,396,19141,314,86065,187,777200,533,806566,411,325566,411,329567,448,293567,448,299317,075,760-452,657,988254,650,208
CFO
779m
+536.68%
19,740,444033,241,41449,386,081175,879,641138,893,825000160,032,607204,379,285274,218,845926,905,3671,600,940,44724,798,541204,544,610122,341,832778,927,922
Dividend
Jul 18, 20240.1 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Truking Technology Limited, established in 2000 and headquartered in Changsha, China, specializes in the research, development, and innovation of machinery for the pharmaceutical and medical industries. The company delivers end-to-end manufacturing solutions for diverse sterile products, encompassing lyophilization, injectable ampoules and vials (for both liquid and powder forms), pre-filling and sealing operations, plastic bottle blow-fill-seal technology, cartridges, non-PVC soft bags, and glass infusion bottles. Its offerings also include specialized fluid processing systems, advanced isolating systems, and dedicated lyophilization laboratories. Operating with a significant international footprint, Truking Technology distributes its products to approximately 40 countries and regions across Asia, Europe, South America, and other global markets.
IPO date
Jan 21, 2014
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122023‑002022‑122022‑002021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT